NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-007-1999-2-JP-12 Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers JP DIV 2017-199639 Expired
NCATS E-091-2016-0-BR-03 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF
MALARIAL PARASITE 		BR National Stage BR1120190075941 Abandoned
NIDDK E-254-2017-0-US-01 INHIBITORS TARGETING THE P51-P66 INTERFACIAL CAVITY OF HIV-1 RT US 62/571,662 Abandoned
NHLBI E-183-2018-0-US-01 3D Bioprinting Of Cardiac Patch With Anisotropic And Perfusable Architecture US 62/571,684 Abandoned
NCI E-276-2016-0-AU-03 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS AU National Stage 2017343643 Issued
NEI E-050-2015-0-DE-10 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa DE EP 16762623.3 Issued
NEI E-050-2015-0-FR-11 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa FR EP 16762623.3 Issued
NEI E-050-2015-0-EP-06 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa EP National Stage 16762623.3 Issued
NEI E-050-2015-0-GB-12 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa GB EP 16762623.3 Issued
NIAID E-257-2016-0-PCT-02 TREATMENT OF TUMORS BY INHIBITION OF CD300F PCT PCT PCT/US2017/056192 Expired
NCI E-276-2016-0-PCT-02 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS PCT PCT PCT/US2017/056124 Expired
NCI E-002-2018-0-US-01 METHODS OF PRODUCING T CELL POPULATIONS USING P38 MAPK INHIBITORS US 62/570,708 Abandoned
NCI E-276-2016-0-CA-04 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS CA National Stage 3039997 Pending
NCATS E-115-2018-0-US-01 EMETINE COMPOUNDS FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION US 62/570,553 Abandoned
NCI E-254-2005-2-US-25 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS US DIV 15/728,455 10428133 Issued PDF
NHLBI E-194-2015-0-US-04 Imaging Systems And Methods Using Floursecent Nanodiamonds US National Stage 15/565,123 10627340 Issued PDF
NHGRI E-044-2013-0-US-07 METHODS FOR TREATING PROGEROID LAMINOPATHIES USING OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA US CON 15/727,483 10398721 Issued PDF
NLM E-107-2010-2-US-15 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/725,917 1073-12-04 Issued PDF
NIAID E-086-2018-2-US-01 Zika Viral Antigen Constructs US 62/568,559 Abandoned
NCI E-182-2017-0-US-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION US 62/568,339 Abandoned
NIMH E-206-2017-0-US-01 Systems and Methods for Probing In Vivo Metabolite Relaxation by Linear Quantification of Spatially Modulated Magnetization US 62/567,991 Abandoned
NIBIB E-150-2016-1-SG-05 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS SG National Stage 11202002882V Issued
NIBIB E-150-2016-1-HK-07 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS HK EP 62020015610.2 Issued
NIBIB E-150-2016-1-DE-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS DE EP 17928082.1 Issued
NIBIB E-150-2016-1-IE-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS IE EP 17928082.1 Issued
NIBIB E-150-2016-1-CH-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS CH EP 17928082.1 Issued
NIBIB E-150-2016-1-FR-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FR EP 17928082.1 Issued
NIBIB E-150-2016-1-GB-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS GB EP 17928082.1 Issued
NIBIB E-150-2016-1-EP-03 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS EP National Stage 17928082.1 Issued
NIBIB E-150-2016-1-CN-02 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS CN National Stage 201780095506.7 Issued
NIBIB E-150-2016-1-JP-04 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS JP National Stage 2020-519137 Issued
NIAID E-279-2016-1-IE-09 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE IE EP 17784795.1 Issued
NIAID E-279-2016-1-DE-06 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE DE EP 17784795.1 Issued
NIAID E-279-2016-1-BE-04 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE BE EP 17784795.1 Issued
NIAID E-279-2016-1-CH-05 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE CH EP 17784795.1 Issued
NIAID E-279-2016-1-FR-07 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE FR EP 17784795.1 Issued
NIAID E-279-2016-1-EP-02 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE EP National Stage 17784795.1 Issued
NIAID E-279-2016-1-GB-08 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE GB EP 17784795.1 Issued
NIAID E-007-2015-0-GB-26 CD47-targeted Therapies For The Treatment Of Infectious Disease GB EP 17194591.8 Issued
NIAID E-007-2015-0-EP-14 CD47-targeted Therapies For The Treatment Of Infectious Disease EP DIV 17194591.8 Issued
NIAID E-007-2015-0-DE-21 CD47-targeted Therapies For The Treatment Of Infectious Disease DE EP 17194591.8 Issued
NIAID E-007-2015-0-FR-25 CD47-targeted Therapies For The Treatment Of Infectious Disease FR EP 17194591.8 Issued
NIAID E-007-2015-0-DK-22 CD47-targeted Therapies For The Treatment Of Infectious Disease DK EP 17194591.8 Issued
NIAID E-007-2015-0-FI-24 CD47-targeted Therapies For The Treatment Of Infectious Disease FI EP 17194591.8 Issued
NIAID E-007-2015-0-IE-28 CD47-targeted Therapies For The Treatment Of Infectious Disease IE EP 17194591.8 Issued
NIAID E-007-2015-0-NO-32 CD47-targeted Therapies For The Treatment Of Infectious Disease NO EP 17194591.8 Issued
NIAID E-007-2015-0-NL-31 CD47-targeted Therapies For The Treatment Of Infectious Disease NL EP 17194591.8 Issued
NIAID E-007-2015-0-LU-30 CD47-targeted Therapies For The Treatment Of Infectious Disease LU EP 17194591.8 Issued
NIAID E-007-2015-0-IT-29 CD47-targeted Therapies For The Treatment Of Infectious Disease IT EP 17194591.8 Issued
NIAID E-007-2015-0-CH-20 CD47-targeted Therapies For The Treatment Of Infectious Disease CH EP 17194591.8 Issued